161 related articles for article (PubMed ID: 15486896)
21. Bone marrow relapse in stage 4 neuroblastoma of children in Shanghai.
Li H; Zhao J; Yang J; Tang J; Zhang T; Jiang H; Shao J
Am J Cancer Res; 2024; 14(1):145-154. PubMed ID: 38323287
[TBL] [Abstract][Full Text] [Related]
22. Advances in the Surgical Treatment of Neuroblastoma.
Luo YB; Cui XC; Yang L; Zhang D; Wang JX
Chin Med J (Engl); 2018 Oct; 131(19):2332-2337. PubMed ID: 30246719
[TBL] [Abstract][Full Text] [Related]
23. Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.
Hao W; Friedman A
PLoS One; 2016; 11(4):e0153508. PubMed ID: 27078836
[TBL] [Abstract][Full Text] [Related]
24. Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma.
Min J; Wu Y; Huang S; Li Y; Lv X; Tang R; Zhao H; Wang J
BMC Pediatr; 2024 Mar; 24(1):205. PubMed ID: 38519890
[TBL] [Abstract][Full Text] [Related]
25. Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.
Mateusiak Ł; Floru S; De Groof TWM; Wouters J; Declerck NB; Debie P; Janssen S; Zeven K; Puttemans J; Vincke C; Breckpot K; Devoogdt N; Hernot S
Adv Sci (Weinh); 2024 Jun; ():e2400700. PubMed ID: 38845188
[TBL] [Abstract][Full Text] [Related]
26. Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades.
Chennakesavalu M; Pudela C; Applebaum MA; Lee SM; Che Y; Naranjo A; Park JR; Volchenboum SL; Henderson TO; Cohn SL; Desai AV
EJC Paediatr Oncol; 2023 Dec; 2():. PubMed ID: 38213818
[TBL] [Abstract][Full Text] [Related]
27. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
28. Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China.
Su Y; Qin H; Chen C; Wang S; Zhang S; Zhang D; Jin M; Peng Y; He L; Wang X; Qian S; Qin M; Ge M; Zhang F; Zeng Q; Wang H; Ma X; Ni X
Pediatr Investig; 2020 Sep; 4(3):157-167. PubMed ID: 33150309
[TBL] [Abstract][Full Text] [Related]
29. Bilateral adrenal neuroblastoma: peculiar pattern of a rare pediatric presentation.
Fawzy M; Ahmed G; Youssef Y; Elkinaai N; Refaat A; Elahmadawy MA; Said F; Elmenawi S
Discov Oncol; 2024 Apr; 15(1):115. PubMed ID: 38607453
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of ABLIM3 confers to the metastasis of neuroblastoma via regulating the cell adhesion molecules pathway.
Gong B; Qu T; Zhang J; Jia Y; Song Z; Chen C; Yang J; Wang C; Liu Y; Jin Y; Cao W; Zhao Q
Comput Struct Biotechnol J; 2024 Dec; 23():1547-1561. PubMed ID: 38645433
[TBL] [Abstract][Full Text] [Related]
31. Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling.
Niazi MKK; Chung JH; Heaton-Johnson KJ; Martinez D; Castellanos R; Irwin MS; Master SR; Pawel BR; Gurcan MN; Weiser DA
Pediatr Dev Pathol; 2017; 20(5):394-402. PubMed ID: 28420318
[TBL] [Abstract][Full Text] [Related]
32. CD20
Qin LJ; Xu H; Li LP; Li SH; Xu SY; Chen K; Yang T; Wang FH; Zuo L; Zeng L; Wang HY
Heliyon; 2024 May; 10(9):e30901. PubMed ID: 38774103
[TBL] [Abstract][Full Text] [Related]
33. Iron deficiency in children at the time of initial neuroblastoma diagnosis.
Fan H; Su Y; Duan C; Zhao Q; Wang X; Zhu S; Zhao W; Jin M; Ma X
Pediatr Investig; 2020 Mar; 4(1):17-22. PubMed ID: 32851337
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma.
Lu R; Wang Y; Xu X; Xie S; Wang Y; Zhong A; Zheng H; Yu Y; Gao X; Guo L
BMC Biochem; 2018 Jul; 19(1):6. PubMed ID: 30064372
[TBL] [Abstract][Full Text] [Related]
35. The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications.
Horwacik I
Cells; 2022 Oct; 11(19):. PubMed ID: 36231134
[TBL] [Abstract][Full Text] [Related]
36. Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.
Śmiłowska K; Śmiłowski M; Partyka R; Kokocińska D; Jałowiecki P
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330458
[TBL] [Abstract][Full Text] [Related]
37. Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis.
Shmakova AA; Klimovich PS; Rysenkova KD; Popov VS; Gorbunova AS; Karpukhina AA; Karagyaur MN; Rubina KA; Tkachuk VA; Semina EV
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205745
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1.
Ye W; Liang F; Ying C; Zhang M; Feng D; Jiang X
Exp Ther Med; 2019 Nov; 18(5):3729-3736. PubMed ID: 31616506
[TBL] [Abstract][Full Text] [Related]
39. Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma.
Burgos-Panadero R; Noguera I; Cañete A; Navarro S; Noguera R
BMC Cancer; 2019 May; 19(1):479. PubMed ID: 31117974
[TBL] [Abstract][Full Text] [Related]
40. UPAR silencing reveals its role in neuroblastoma.
Kalinina N
Oncotarget; 2018 Jul; 9(58):31163-31164. PubMed ID: 30131841
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
